ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

Supernus Pharmaceuticals has won Food and Drug Administration approval for its Onapgo device to treat patients with Parkinson's disease.

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, ...

Christine Stanley, 62, was told by her GP that she was "too young" to develop Parkinson's Disease, but she lived in fear for ...

NEW YORK, NY / ACCESS Newswire / / Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced drug delivery systems, today announced the positive results from ...

The Parkinson's Foundation will host Parkinson's Revolution – an indoor and virtual cycling experience – on Saturday, Feb. 22 in 24 cities across the U.S. Parkinson's Revolution is a high-energy, high ...

There’s no cure for restless legs syndrome – a distressing disorder that mainly affects sufferers at night – but there are ...

Poor Sleep and Reduced Quality of Life in Parkinson’s Patients: Study FindsA new study by researchers found that an overwhelming 84% of patients ...

Researchers in India have developed a new nanoformulation that may improve the safety and efficacy of Parkinson's <a target=_blank href= ...

Christine Stanley said that after years of her GP claiming her symptoms were a legacy of cancer treatment, she decided to pay ...

A new study by researchers found that an overwhelming 84% of patients with Parkinson’s disease report struggling with sleep ...